We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ANRO market cap is 115.7M. The company's latest EPS is USD -1.3461 and P/E is -3.19.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | |||
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -11.77M | -14.39M | -18.34M | -18.89M |
| Net Income | -11.22M | -13.42M | -16.03M | -16.78M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -29.19M | -37.81M |
| Net Income | -27.71M | -36.31M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | |||
| Total Assets | 86.63M | 209.92M | 197.36M | 191.61M |
| Total Liabilities | 16.82M | 16.82M | 17.58M | 26.56M |
| Total Equity | -71.67M | 193.1M | 179.78M | 165.05M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 50.85M | 86.63M |
| Total Liabilities | 17.03M | 16.82M |
| Total Equity | -38.41M | -71.67M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | |||
| Operating | -33.45M | -10.98M | -22.68M | -34.4M |
| Investing | -470k | -224k | -564k | -1.57M |
| Financing | 68.13M | 134.56M | 134.33M | 135.64M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Operating | -20.39M | -33.45M |
| Investing | -732k | -470k |
| Financing | 43.79M | 68.13M |
| Market Cap | 115.7M |
| Price to Earnings Ratio | -3.19 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.4 |
| Price to Book Ratio | 1.66 |
| Dividend Yield | - |
| Shares Outstanding | 26.97M |
| Average Volume (1 week) | 165.44k |
| Average Volume (1 Month) | 201.82k |
| 52 Week Change | -80.50% |
| 52 Week High | 24.00 |
| 52 Week Low | 3.56 |
| Spread (Intraday) | 0.49 (10.58%) |
| Company Name | Alto Neuroscience Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.altoneuroscience.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
